MDxHealth (MDXH) Receivables - Other (2020 - 2023)

MDxHealth has disclosed Receivables - Other across 4 years of filings, most recently posting $36000.0 for Q4 2023.

• Receivables - Other for Q4 2023 came in at $36000.0, down 99.62% year-over-year; the trailing twelve-month figure through Dec 2023 was $36000.0 (down 99.62% YoY), and the FY2023 annual result was $36000.0, down 99.62% from the prior year.
• Receivables - Other came in at $36000.0 for Q4 2023 at MDxHealth, down from $9.4 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $9.4 million in Q4 2022 to a low of $36000.0 in Q4 2023.
• The 4-year median for Receivables - Other is $4.2 million (2020), against an average of $4.4 million.
• Across the five-year window, Receivables - Other surged 104.21% in 2022 and plunged 99.62% in 2023, its largest moves.
• MDxHealth's Receivables - Other stood at $3.8 million in 2020, then grew by 21.51% to $4.6 million in 2021, then soared by 104.21% to $9.4 million in 2022, then slumped by 99.62% to $36000.0 in 2023.
• The last three Receivables - Other figures came in at $36000.0 (Q4 2023), $9.4 million (Q4 2022), and $4.6 million (Q4 2021), per Business Quant data.